Endobronchial valve therapy — a breakthrough bronchoscopic approach for selected emphysema patients — reduces lung hyperinflation and improves breathing without surgical incision. Keyhole lung volume reduction surgery for suitable patients. Specialist assessment at London Bridge Hospital.
Endobronchial valve (EBV) therapy is a minimally invasive bronchoscopic procedure — no surgical incision is required. Small one-way valves are placed in the airways supplying the most diseased parts of the lung. The targeted area deflates, while healthier lung tissue expands and breathing mechanics improve.
In suitable patients, EBV therapy produces meaningful improvements in breathlessness, exercise capacity, and quality of life. Improvement typically begins within days to weeks as the target lobe deflates.
For patients not suitable for valve therapy, I also offer keyhole (VATS) lung volume reduction surgery — removing the most severely damaged emphysematous tissue to allow remaining lung to function more effectively.
Assessment involves clinical consultation, high-resolution CT scanning, comprehensive lung function tests, and in some cases a 6-minute walk test and echocardiogram. A clear recommendation is provided following specialist review of all results.
If you have been told there are no further treatment options for emphysema or severe COPD, it is worth seeking a second opinion. Endobronchial valve therapy and LVRS have enabled patients with severe disease to experience meaningful improvement in quality of life.
Request a Second Opinion →EBV therapy is available on the NHS at selected centres. Private assessment and treatment is also available for patients who wish to access care promptly. All options — NHS and private — are discussed openly at consultation.
Questions patients most commonly ask about endobronchial valve therapy and lung volume reduction surgery.
Book a ConsultationAppointments within 2–3 days. Self-referrals welcome. All options discussed openly.
Book a Consultation →